Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TLRY
TLRY logo

TLRY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
6.395
Open
6.320
VWAP
6.11
Vol
2.77M
Mkt Cap
697.88M
Low
5.930
Amount
16.91M
EV/EBITDA(TTM)
26.19
Total Shares
116.51M
EV
707.13M
EV/OCF(TTM)
--
P/S(TTM)
0.76
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. It operates through four segments: cannabis operations, beverage operations, distribution operations, and the wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The beverage operations, which encompasses the production, marketing and of beverage products. The distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers. The Wellness products, which encompasses wellness and better-for-you foods and beverages. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, Chowie Wowie and others. It supports over 40 brands in over 20 countries, including cannabis offerings, hemp-based foods and craft beverages.
Show More

Events Timeline

(ET)
2026-03-26
07:20:00
Tilray Partners with Magnum Ice Cream to Launch New Beverage Line
select
2026-03-19 (ET)
2026-03-19
11:20:00
Representative Proposes Bill to Protect Legal Cannabis Businesses
select
link
2026-03-19
07:30:00
Tilray Medical Expands Medical Cannabis Portfolio in Australia
select
2026-03-18 (ET)
2026-03-18
08:50:00
Aptera Motors Borrow Rate Increases to 391.05%
select
2026-03-18
07:20:00
Breckenridge Distillery Partners with Cheba Hut to Launch Whiskey
select
2026-03-16 (ET)
2026-03-16
07:30:00
Tilray Brands Acquires BrewDog Assets
select
2026-03-13 (ET)
2026-03-13
08:50:00
Significant Increases in Indicative Borrow Rates for Liquid Options
select
2026-03-12 (ET)
2026-03-12
07:30:00
Tilray Pharma Forms Strategic Partnership with Multiple Companies
select

News

Newsfilter
9.5
03-25Newsfilter
Tilray Brands to Release Q3 Fiscal Results on April 1, 2026
  • Earnings Release Schedule: Tilray Brands will announce its financial results for the third fiscal quarter ending February 28, 2026, before the market opens on April 1, 2026, which is expected to provide key financial metrics for assessing company performance.
  • Conference Call Details: The company will host a live conference call at 8:30 AM Eastern Time on the same day, aiming to share financial results and address investor inquiries, thereby enhancing transparency and investor confidence.
  • Global Business Operations: Tilray operates in Canada, the United States, Europe, Australia, and Latin America, focusing on being a transformative force in the beverage, cannabis, and wellness industries, thereby increasing its global market influence.
  • Brand Strategy: Tilray's mission is to be a leading premium lifestyle company with over 40 brands, including cannabis products, hemp-based foods, and craft beverages, aimed at enhancing consumer experiences through innovative offerings.
seekingalpha
8.5
03-19seekingalpha
Tilray Medical Expands Product Portfolio in Australia
  • Portfolio Expansion: Tilray Medical announced its largest portfolio expansion in Australia to date, aimed at meeting the rising demand for medical cannabis and further solidifying its position in the local market.
  • Compliance Supply Chain: The company ensures the reliability and compliance of its EU-GMP certified medical cannabis products through established prescriber, pharmacy, and clinical distribution channels, enhancing customer trust.
  • New Product Launches: Over the coming months, Tilray Medical will introduce new products under its Redecan and Good Supply brands, aiming to provide healthcare professionals and patients with more treatment options, thereby increasing market competitiveness.
  • Market Commitment: This expansion reflects Tilray's ongoing commitment to the Australian medical system, indicating the company's intention to continue investing in compliant medical cannabis supply to meet the growing market demand.
Fool
9.5
03-18Fool
Tilray Brands Faces Mixed Financial Results Amid Market Uncertainty
  • Financial Performance: Tilray Brands reported a record revenue of $217.5 million for Q2 FY2026, although the year-over-year growth was only 3%, indicating a lack of robust revenue growth.
  • Improved Net Loss: The net loss per share significantly narrowed from $0.99 to $0.41, and the company transformed a net debt of $3.8 million into a net cash position of $27.4 million, reflecting some progress in financial health.
  • Market Uncertainty: Despite the potential of the U.S. cannabis market, regulatory hurdles and competition from well-established brands pose significant challenges for Tilray, particularly from larger companies with more resources.
  • Investment Caution: Given Tilray's mediocre financial results and uncertain future prospects, analysts advise investors to steer clear of the stock to avoid potential risks.
NASDAQ.COM
9.5
03-18NASDAQ.COM
Tilray's Financial Results Improve but Uncertain Outlook Persists
  • Financial Highlights: Tilray's revenue for Q2 FY 2026 reached $217.5 million, marking a record for this period, although the 3% year-over-year growth indicates ongoing challenges in revenue generation.
  • Narrowing Net Loss: The net loss per share significantly decreased from $0.99 to $0.41, suggesting some progress in financial improvement, yet the company remains unprofitable, highlighting its fragile financial health.
  • Cash Flow Improvement: Tilray transformed a net debt of $3.8 million in Q1 into a net cash position of $27.4 million, although the negative adjusted free cash flow indicates ongoing cash management pressures.
  • Uncertain Market Outlook: Despite the potential of the U.S. cannabis market, Tilray faces regulatory challenges and competitive pressures that may hinder growth, particularly from industry giants with greater capital and brand recognition, prompting caution for investors considering the stock.
Fool
7.5
03-16Fool
Tilray's Diversification Strategy Faces Challenges
  • Revenue Structure Shift: Tilray's latest financial report indicates that for the six months ending November 30, 2025, total sales reached $427 million, a modest 4% increase year-over-year, yet its cannabis business accounted for only 31%, highlighting a trend towards revenue diversification.
  • Beverage Business Growth: With beverage revenue hitting $106 million, Tilray's beverage segment has become its third-largest revenue source, suggesting that its strategy of acquiring beverage brands in the U.S. market is beginning to pay off, potentially positioning it favorably in the cannabis beverage market.
  • Poor Market Performance: Despite some progress in diversification, Tilray's stock has fallen over 20% this year, reflecting investor concerns about the company's future profitability and indicating that the effectiveness of its growth strategy remains in question.
  • Acquisition Risks: While Tilray's expansion strategy may drive revenue growth, it also increases the complexity of management and oversight, and if the integration of newly acquired brands is not handled effectively, it could lead to rising costs that negatively impact long-term investment value.
NASDAQ.COM
7.5
03-16NASDAQ.COM
Tilray's Diversification Strategy Faces Challenges
  • Weak Sales Growth: Tilray reported $427 million in sales for the six months ending November 30, 2025, reflecting a modest 4% increase, with its cannabis business contributing only 31% of total revenue, indicating struggles in its core market.
  • Diversified Revenue Streams: Despite the lackluster performance in cannabis, Tilray's distribution segment generated $159 million, while beverages accounted for $106 million, showcasing the company's strategy to seek new growth avenues, particularly through acquisitions in the U.S. beverage market.
  • Uncertain Market Outlook: While Tilray's expansion in beverages may position it well for future legalization, the company continues to incur losses in recent quarters, leading to skepticism about the effectiveness of its growth strategy and a stock price decline of over 20% this year.
  • Investor Confidence Lacking: The absence of progress on profitability has prevented Tilray from becoming a safer growth stock, with analysts advising caution in investing, especially as the company did not make it onto the list of top investment stocks.
Wall Street analysts forecast TLRY stock price to rise
4 Analyst Rating
Wall Street analysts forecast TLRY stock price to rise
1 Buy
3 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
8.50
Averages
9.57
High
10.00
Current: 0.000
sliders
Low
8.50
Averages
9.57
High
10.00
TD Cowen
Buy
downgrade
$10 -> $7
AI Analysis
2026-03-30
New
Reason
TD Cowen
Price Target
$10 -> $7
AI Analysis
2026-03-30
New
downgrade
Buy
Reason
TD Cowen lowered the firm's price target on Tilray to $7 from $10 and keeps a Buy rating on the shares. The firm is lowering its EBITDA estimates for fiscal 3Q26 and FY26 mostly from higher aluminum costs and the risk that the company's Beverage business may not be fully hedged. Aluminum prices have increased further this year due to the supply shocks from the Iran conflict.
Alliance Global
Neutral
downgrade
$10 -> $9
2026-03-03
Reason
Alliance Global
Price Target
$10 -> $9
2026-03-03
downgrade
Neutral
Reason
Alliance Global lowered the firm's price target on Tilray to $9 from $10 and keeps a Neutral rating on the shares after the company announced the acquisition of certain assets of BrewDog. The firm views the ability for Tilray to turn around trends and capitalize on synergies as key to the success of the acquisition.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TLRY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Tilray Brands Inc (TLRY.O) is -27.23, compared to its 5-year average forward P/E of -19.85. For a more detailed relative valuation and DCF analysis to assess Tilray Brands Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-19.85
Current PE
-27.23
Overvalued PE
-6.01
Undervalued PE
-33.69

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
39.98
Current EV/EBITDA
17.65
Overvalued EV/EBITDA
79.85
Undervalued EV/EBITDA
0.12

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
3.19
Current PS
1.29
Overvalued PS
6.12
Undervalued PS
0.27

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Give me the top 5 cannabis companies
Intellectia · 4 candidates
Market Cap: >= 500.00MRevenue Ttm: >= 100.00MRegion: USThemes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.52B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.43B
CRON logo
CRON
Cronos Group Inc
947.63M
TLRY logo
TLRY
Tilray Brands Inc
736.32M
Should I Buy cannabis stocks?
Intellectia · 9 candidates
Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
what cannabis stocks would you buy?
Intellectia · 4 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryQuarter Revenue Yoy Growth: >= 0.0%Monthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
SNDL logo
SNDL
SNDL Inc
386.25M
ACB logo
ACB
Aurora Cannabis Inc
204.15M
cannabis
Intellectia · 8 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
marijuana stocks
Intellectia · 8 candidates
Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M
which. cannabisindustry should I invest in
Intellectia · 2 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
Cannibus stocks
Intellectia · 4 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryBeta: ModerateRisk, HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
stocks that went down now
Intellectia · 25 candidates
Beta: HighRiskWeekly Average Turnover: >= 10,000,000Week Price Change Pct: <= $-7.00Month Price Change Pct: <= $-12.00Quarter Price Change Pct: <= $-20.00
Ticker
Name
Market Cap$
top bottom
ORCL logo
ORCL
Oracle Corp
499.58B
INTU logo
INTU
Intuit Inc
146.07B
CEG logo
CEG
Constellation Energy Corp
106.67B
HOOD logo
HOOD
Robinhood Markets Inc
95.24B
NET logo
NET
Cloudflare Inc
59.54B
TEAM logo
TEAM
Atlassian Corp
32.21B
Top cannabis stocks to buy
Intellectia · 9 candidates
Market Cap: >= 50.00MRevenue Ttm: >= 10.00MThemes: The Cannabis Industry
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M

Whales Holding TLRY

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Tilray Brands Inc (TLRY) stock price today?

The current price of TLRY is 5.99 USD — it has decreased -5.22

What is Tilray Brands Inc (TLRY)'s business?

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. It operates through four segments: cannabis operations, beverage operations, distribution operations, and the wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The beverage operations, which encompasses the production, marketing and of beverage products. The distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers. The Wellness products, which encompasses wellness and better-for-you foods and beverages. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, Chowie Wowie and others. It supports over 40 brands in over 20 countries, including cannabis offerings, hemp-based foods and craft beverages.

What is the price predicton of TLRY Stock?

Wall Street analysts forecast TLRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TLRY is9.57 USD with a low forecast of 8.50 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Tilray Brands Inc (TLRY)'s revenue for the last quarter?

Tilray Brands Inc revenue for the last quarter amounts to 217.51M USD, increased 3.11

What is Tilray Brands Inc (TLRY)'s earnings per share (EPS) for the last quarter?

Tilray Brands Inc. EPS for the last quarter amounts to -0.41 USD, decreased -58.59

How many employees does Tilray Brands Inc (TLRY). have?

Tilray Brands Inc (TLRY) has 2842 emplpoyees as of March 31 2026.

What is Tilray Brands Inc (TLRY) market cap?

Today TLRY has the market capitalization of 697.88M USD.